Company news

Abera Bioscience AB news in 2026

Abera Bioscience AB's news releases, calls and decks from 2026, newest first.

ABERA: 7% organic growth and stable margins in Q1 2026, with strong energy and infrastructure demand

May 12, 2026

ABERA: Transition to clinical-stage vaccines, strong financing, and expanded R&D drive future growth

February 12, 2026

Decks in 2026

Investor Presentation (2026)
Investor deck · 33 slides · 2026